Evidence of association of APOE with age-related macular degeneration - a pooled analysis of 15 studies

GJ McKay, CC Patterson, U Chakravarthy, S Dasari, Caroline Klaver, Hans Vingerling, Lintje Ho, PTVM (Paulus) de Jong, AE Fletcher, IS Young, JH Seland, M Rahu, G Soubrane, L Tomazzoli, F Topouzis, J Vioque, AD Hingorani, R Sofat, M Dean, J SawitzkeJM Seddon, I Peter, AR Webster, AT Moore, JRW Yates, V Cipriani, LG Fritsche, BHF Weber, CN Keilhauer, AJ Lotery, S Ennis, ML Klein, PJ Francis, D Stambolian, A Orlin, MB Gorin, DE Weeks, CL Kuo, A Swaroop, M Othman, A Kanda, W Chen, GR Abecasis, AF Wright, C Hayward, PN Baird, RH Guymer, J Attia, A Thakkinstian, G Silvestri

Research output: Contribution to journalArticleAcademicpeer-review

126 Citations (Scopus)


Age-related macular degeneration (AMD) is the most common cause of incurable visual impairment in high-income countries. Previous studies report inconsistent associations between AMD and apolipoprotein E (APOE), a lipid transport protein involved in low-density cholesterol modulation. Potential interaction between APOE and sex, and smoking status has been reported. We present a pooled analysis (n = 21,160) demonstrating associations between late AMD and APOe4 (odds ratio [OR] = 0.72 per haplotype; confidence interval [CI]: 0.650.74; P = 4.41 x 10-11) and APOe2 (OR = 1.83 for homozygote carriers; CI: 1.043.23; P = 0.04), following adjustment for age group and sex within each study and smoking status. No evidence of interaction between APOE and sex or smoking was found. Ever smokers had significant increased risk relative to never smokers for both neovascular (OR = 1.54; CI: 1.381.72; P = 2.8 x 10(-15)) and atrophic (OR = 1.38; CI: 1.181.61; P = 3.37 x 10(-5)) AMD but not early AMD (OR = 0.94; CI: 0.861.03; P = 0.16), implicating smoking as a major contributing factor to disease progression from early signs to the visually disabling late forms. Extended haplotype analysis incorporating rs405509 did not identify additional risks beyond e2 and e4 haplotypes. Our expanded analysis substantially improves our understanding of the association between the APOE locus and AMD. It further provides evidence supporting the role of cholesterol modulation, and low-density cholesterol specifically, in AMD disease etiology. 32:14071416, 2011. (C) 2011 Wiley Periodicals, Inc.
Original languageUndefined/Unknown
Pages (from-to)1407-1416
Number of pages10
JournalHuman Mutation
Issue number12
Publication statusPublished - 2011

Research programs

  • EMC NIHES-01-64-01
  • EMC OR-01-60-01

Cite this